PolityLens

H.R. 6485: Skinny Labels, Big Savings Act

H.R. 6485 is a federal bill in the 119th Congress. Currently, generic drug manufacturers can get approval to sell cheaper versions of drugs for specific uses that are no longer protected by patents. However, a court decision has made it possible for these manufacturers to be sued for patent infringement… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.

Loading full bill…